Accès à distance ? S'identifier sur le proxy UCLouvain
Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2008 |
| Language | Anglais |
| Conference | "50th Annual Meeting of the American- Society-of-Hematology", San Francisco(Ca) (Dec 06-09, 2008) |
| Journal information | "Blood" - Vol. 112, no. 11, p. 1018 (2008) |
| Peer reviewed | yes |
| issn | 0006-4971 |
| e-issn | 1528-0020 |
| Publisher | Amer Soc Hematology (Washington) |
| Affiliation | UCL - Autre |
| Links |
| Bibliographic reference | Sonet, Anne ; Graux, Carlos ; Maertens, Johan ; Hartog, Christine-Maria ; Duyster, Justus ; et. al. Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies.50th Annual Meeting of the American- Society-of-Hematology (San Francisco(Ca), Dec 06-09, 2008). In: Blood, Vol. 112, no. 11, p. 1018 (2008) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59032 |